These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33073359)

  • 1. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.
    Oja AE; Saris A; Ghandour CA; Kragten NAM; Hogema BM; Nossent EJ; Heunks LMA; Cuvalay S; Slot E; Linty F; Swaneveld FH; Vrielink H; Vidarsson G; Rispens T; van der Schoot E; van Lier RAW; Ten Brinke A; Hombrink P
    Eur J Immunol; 2020 Dec; 50(12):1998-2012. PubMed ID: 33073359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4
    Pušnik J; Richter E; Schulte B; Dolscheid-Pommerich R; Bode C; Putensen C; Hartmann G; Alter G; Streeck H
    Cell Rep; 2021 Jun; 35(13):109320. PubMed ID: 34146478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.
    Saletti G; Gerlach T; Jansen JM; Molle A; Elbahesh H; Ludlow M; Li W; Bosch BJ; Osterhaus ADME; Rimmelzwaan GF
    Sci Rep; 2020 Dec; 10(1):21447. PubMed ID: 33293664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
    Newell KL; Clemmer DC; Cox JB; Kayode YI; Zoccoli-Rodriguez V; Taylor HE; Endy TP; Wilmore JR; Winslow GM
    PLoS One; 2021; 16(1):e0244855. PubMed ID: 33507994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
    Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.
    Kos I; Balensiefer B; Lesan V; Kaddu-Mulindwa D; Thurner L; Christofyllakis K; Bittenbring JT; Ahlgrimm M; Seiffert M; Wagenpfeil S; Bewarder Y; Neumann F; Rixecker T; Smola S; Link A; Krawczyk M; Lammert F; Lepper PM; Bals R; Stilgenbauer S; Bewarder M
    Eur J Immunol; 2021 Jun; 51(6):1449-1460. PubMed ID: 33788264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.
    Schwarz T; Heiss K; Mahendran Y; Casilag F; Kurth F; Sander LE; Wendtner CM; Hoechstetter MA; Müller MA; Sekul R; Drosten C; Stadler V; Corman VM
    Front Immunol; 2021; 12():629185. PubMed ID: 33833755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
    Larsen MD; de Graaf EL; Sonneveld ME; Plomp HR; Nouta J; Hoepel W; Chen HJ; Linty F; Visser R; Brinkhaus M; Šuštić T; de Taeye SW; Bentlage AEH; Toivonen S; Koeleman CAM; Sainio S; Kootstra NA; Brouwer PJM; Geyer CE; Derksen NIL; Wolbink G; de Winther M; Sanders RW; van Gils MJ; de Bruin S; Vlaar APJ; ; ; Rispens T; den Dunnen J; Zaaijer HL; Wuhrer M; Ellen van der Schoot C; Vidarsson G
    Science; 2021 Feb; 371(6532):. PubMed ID: 33361116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.
    Riou C; du Bruyn E; Stek C; Daroowala R; Goliath RT; Abrahams F; Said-Hartley Q; Allwood BW; Hsiao NY; Wilkinson KA; Arlehamn CSL; Sette A; Wasserman S; Wilkinson RJ;
    J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.
    Sattler A; Angermair S; Stockmann H; Heim KM; Khadzhynov D; Treskatsch S; Halleck F; Kreis ME; Kotsch K
    J Clin Invest; 2020 Dec; 130(12):6477-6489. PubMed ID: 32833687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Qu J; Wu C; Li X; Zhang G; Jiang Z; Li X; Zhu Q; Liu L
    Clin Infect Dis; 2020 Nov; 71(16):2255-2258. PubMed ID: 32337590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology.
    Khanolkar A
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B careful: Humoral responses and COVID-19 severity.
    Fanous H; Guerrero-Pena A; Pillai A
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33277373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.